1-7 of 7
Michael T. Maris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Comorbidities on Early and Late Mortalities After Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Rainer Storb, MD, Brenda M. Sandmaier, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Paul J Martin, MD, Barry Storer, PhD
Journal: Blood
Blood (2011) 118 (21): 326.
https://doi.org/10.1182/blood.V118.21.326.326
Published: 2011
Journal Articles

Interaction of Age and Comorbidities and Their Impacts on Hematopoietic Cell Transplantation (HCT) Outcomes

Fabiana Ostronoff, MD, Barry Storer, PhD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J. Martin, MD, Frederick R. Appelbaum, M.D., David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, MSc
Journal: Blood
Blood (2011) 118 (21): 665.
https://doi.org/10.1182/blood.V118.21.665.665
Published: 2011
Journal Articles

Impact of Pre-Transplant Comorbidities on the Rate of- and Mortality-Following Acute Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Rainer Storb, MD, Paul J Martin, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Ted A. Gooley, PhD
Journal: Blood
Blood (2011) 118 (21): 156.
https://doi.org/10.1182/blood.V118.21.156.156
Published: 2011
Journal Articles

Multi-Institutional Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes

Mohamed L. Sorror, MD, MSc, Fabiana Ostronoff, MD, Rainer Storb, MD, Smita Bhatia, MD, MPH, Richard T. Maziarz, MD, Michael A. Pulsipher, MD, Michael T. Maris, MD, H. Joachim Deeg, M.D., Paul J Martin, MD, Frederick R. Appelbaum, MD, David G. Maloney, MD, PhD, Brenda M Sandmaier, MD, Barry Storer, PhD
Journal: Blood
Blood (2011) 118 (21): 145.
https://doi.org/10.1182/blood.V118.21.145.145
Published: 2011
Journal Articles

Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Georg N. Franke, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Edward Agura, MD, Michael T. Maris, MD, James Wade, MD, Michael A. Pulsipher, MD, Richard T Maziarz, MD, Firoozeh Sahebi, MS, Peter McSweeney, MD, Benedetto Bruno, MD, Lars indelov, V, MD, Andrew M. Yeager, MD, Andrew Rezvani, MD, Dietger W Niederwieser, MD, Karl G. Blume, MD, Rainer F. Storb, MD, David G. Maloney, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1292.
https://doi.org/10.1182/blood.V116.21.1292.1292
Published: 2010
Journal Articles

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Leanthe Braunert, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Christopher Bredeson, Richard T Maziarz, MD, Michael A. Pulsipher, MD, Edward Agura, MD, Michael T. Maris, MD, Lars Vindelov, MD, Firoozeh Sahebi, M.D., Peter McSweeney, Benedetto Bruno, MD, Amelia Langston, MD, Rainer F. Storb, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 2364.
https://doi.org/10.1182/blood.V116.21.2364.2364
Published: 2010
Journal Articles

Sequential Autologous Followed by Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors Improves Outcomes of Patients (pts) with Bulky Lymphoma or Chronic Lymphocytic Leukemia (CLL)

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M Sandmaier, MD, Thomas Chauncey, MD, Michael T. Maris, MD, Rainer F. Storb, MD, David G. Maloney
Journal: Blood
Blood (2010) 116 (21): 2365.
https://doi.org/10.1182/blood.V116.21.2365.2365
Published: 2010